Jupiter Endovascular Secures Oversubscribed $40M+ Series B to Advance TFX Technology

Meta description: Jupiter Endovascular completed an oversubscribed Series B funding exceeding $40 million, backed by leading…

Ansa Biotechnologies Raises $54.4M in Series B to Scale DNA Synthesis Operations

Meta description: Ansa Biotechnologies secures $54.4 million in an oversubscribed Series B funding round to expand…

Aarvik Therapeutics Secures Series Seed 2 Funding to Advance ADC Pipeline

Meta description: Aarvik Therapeutics closes Series Seed 2 funding to progress its proprietary antibody drug conjugate…

SEED Therapeutics Secures $30M Series A-3 Funding and Prepares for Clinical Trials

Meta description: SEED Therapeutics closes $30M Series A-3 funding, gains FDA clearance for lead program, and…

SEED Therapeutics Closes $6M Series A-3 Funding, Advances to Clinical Stage

Meta description: SEED Therapeutics completes $6M Series A-3 funding, backed by major pharma partners, and moves…